Extension of Time to File SOU

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: SUNLENCA (see, http://uspto.report/TM/88823358/mark.png)
SERIAL NUMBER: 88823358

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Gilead Sciences Ireland UC, having an address of
      IDA BUSINESS AND TECHNOLOGY PARK
      CARRIGTOHILL, CO. CORK,
      Ireland
      Phone: 650-522-2401
      Fax: (650) 522-5575
      Email: XXXX
Proposed: Gilead Sciences Ireland UC, having an address of
      IDA BUSINESS AND TECHNOLOGY PARK
      CARRIGTOHILL, CO. CORK,
      Ireland
      Phone: 650-522-2401
      Fax: (650) 522-5575
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 11/24/2020.

For International Class 005:
Current identification: Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Gretchen R. Stroud
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): TMTeam@gilead.com

Correspondence Information (proposed):
      Gretchen R. Stroud
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): TMTeam@gilead.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /jack wessel/      Date Signed: 09/28/2021
Signatory's Name: Jack Wessel
Signatory's Position: Senior Counsel, IP
Signatory's Phone: 650-425-8540
Signature method: Sent to third party for signature

PAYMENT: 88823358
PAYMENT DATE: 09/28/2021

Serial Number: 88823358
Internet Transmission Date: Tue Sep 28 14:26:02 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XX-202109281426027
52224-88823358-78198dfe7aa56478af0578cec
bb4f7826a46e1964a2c66a2efea9be65d843f4-D
A-26000447-20210921184654726479